Filter your search
- $2,250.00 – $5,500.00Contract Manufacturers seeking to partner with global marketers can find the best opportunities making the medical devices that drive the best sales and growth for global marketers. This report covers contract manufacturing (CM) in several medical devices that show promising growth for the next five years. The report details the following areas and provides forecasts […]September 1, 2008$1,500.00 – $6,995.00Infusion pumps are used to infuse necessary fluids, which includes medications and/or nutrients, to a patient’s circulatory system. Infusion pumps are often used in situations where continuous monitoring and treatment by a nurse or other health staff would be expensive, impractical, or unreliable. For the purpose of this study, we have classified two general types […]September 1, 2008$3,500.00 – $7,000.00Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It is a safe, feasible, and patient-friendly method of performing an operation. The report includes product information, procedure volume data, world demographics; and other general issues affecting the MIS device market. Information is presented as a worldwide overview, with […]September 1, 2008$2,995.00 – $5,000.00A perfect supplemental information resource for customers who have already purchased The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition, The IVD Market Research Supplement bundle studies and quantifies in greater detail some of the important areas that will have a transforming impact on the diagnostic industry: • Companies are now performing diagnostic tests […]August 1, 2008$1,500.00 – $7,000.00Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization […]August 1, 2008$2,995.00 – $5,990.00The market for respiratory disposables and reusable accessories is witnessing dynamic changes. The market factors influencing demand in the U.S. are also present in Europe and the Asia/Pacific region — the aging of the population, technological trends and society’s acceptance of people with disabilities. Kalorama’s World Market for Respiratory Equipment and Disposables represents the third […]August 1, 2008$1,500.00 – $7,000.00The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff safety, minimize errors, improve the handling of specimens, and allow labs to reallocate personnel to more important and productive […]August 1, 2008$1,500.00 – $4,995.00Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer’s Disease has encouraged development of new treatments. There is an opportunity for pharmaceutical […]August 1, 2008$3,500.00 – $7,000.00The aging of the population, namely the baby boomer demographic segment is driving the market for facial rejuvenation products. The size and wealth of this aging segment and its overwhelming desire to retain a youthful appearance are driving growth for aesthetic procedures. Worldwide, billions of dollars are spent annually on facial rejuvenation products and services. […]August 1, 2008$3,995.00 – $7,990.00As Kalorama publishes its second edition of this detailed report on the long term care industry and all of its segments, there is no decrease in demand or activity for everything from nursing homes, to home care, to hospices. The U.S. long care industry has experienced strong growth from 2002 through 2007 and this growth […]July 1, 2008
